
Purple Biotech Ltd.
PPBTHealthcare|Biotechnology|IL
$1.31
+0.06 (+4.80%)
DCF Value
$1.39
Tangible Book / Share
$0.45
Cash / Share
$0.56
Next Earnings Report
Nov 13, 2026
EPS est. -$2.88
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest Nov 6, 2026 (F-3/A). Possible dilution.
Upcoming Data Readouts (1)
Feb 2030
Est. completion
P1P2Head and Neck Cancer
NT219 Combined With Standard of Care Biologic Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
NCT06919666n=29
Recent Press Releases
SEC Filings (79)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 6, 2026 | F-3/A | Shelf registration | DocumentIndex |
| Oct 5, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Sep 9, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Sep 2, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 10, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Aug 7, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jul 29, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jun 23, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jun 11, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| May 20, 2026 | F-3 | Shelf registration | DocumentIndex |
| May 15, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| May 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Apr 27, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Apr 23, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Mar 25, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Mar 19, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Mar 19, 2026 | 20-F | Annual report (foreign) | DocumentIndex |
| Mar 17, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Mar 13, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Feb 25, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Feb 13, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jan 13, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jan 7, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Dec 16, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Dec 11, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Nov 19, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Nov 14, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Nov 7, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Oct 29, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Oct 28, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Oct 20, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Sep 19, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Sep 19, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Sep 16, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Sep 10, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Sep 10, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Sep 9, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Sep 9, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Sep 9, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |